| Enrollment | Baseline | Allocation | Follow-up | ||
---|---|---|---|---|---|---|
t-1 | t0 | Â | t1 | t2 | t3 | |
Enrollment | ||||||
 Eligibility screen | X |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |
 Baseline assessment |  | X |  |  |  |  |
 Allocation |  |  | X |  |  |  |
Interventions | ||||||
TAU + BtB | Â | Â | X | X | X | Â |
 TAU |  |  | X | X | X |  |
Assessments | ||||||
 Socio-demographic characteristics |  | X |  |  |  |  |
 TLFB |  | X |  | X | X | X |
 AUDIT |  | X |  | X | X | X |
 CES-D |  | X |  | X | X | X |
 EQ-5D-5L |  | X |  | X | X | X |
 RAND-36 |  | X |  | X | X | X |
 DMQ-R |  | X |  | X | X |  |
 MHI-5 |  | X |  | X | X | X |
 ZUF-8 |  |  |  | X |  |  |
 TIC-P |  | X |  | X | X | X |
 DERS-18 |  | X |  |  | X |  |
 GAD-7 |  | X |  |  | X |  |
 PAI-BOR |  | X |  |  | X |  |
 CTQ-SF |  | X |  |  |  |  |
 PCL-5 |  | X |  |  | X |  |
 RES |  | X |  |  | X |  |
 Impact COVID-19 |  | X |  | X | X | X |